MedPath

Comparative Evaluation of PUSPENs and C&Cs

Terminated
Conditions
Opioid-Related Disorders
Interventions
Registration Number
NCT02698098
Lead Sponsor
University of Malaya
Brief Summary

This observational study compares the health and social outcomes between opioid-dependent individuals who are either recently released from a compulsory drug detention center (CDDC) or recently discharged from a voluntary treatment center (VTC) providing methadone maintenance therapy, in Malaysia.

Detailed Description

In July 2010, the National Anti-Drug Agency of Malaysia (NADA) introduced a non-punitive system of treatment and care for people who use drugs, voluntary treatment centers (VTCs), called 'Cure \& Care' clinics, offering free methadone maintenance therapy (MMT) to opioid-dependent drug users. These centers were opened alongside existing compulsory drug detention centers (CDDCs), where people who use drugs continue to be detained involuntarily without access to evidence-based treatment. Given that both of these programs are operated by NADA but espouse vastly different responses to drug use, we compared health and social outcomes between opioid-dependent individuals recently released from CDDCs and recently initiated into MMT in the new VTCs.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
281
Inclusion Criteria
  • Meets Diagnostic and Statistical Manual-IV criteria for opioid dependence
  • Physically and psychologically capable of understanding and undergoing informed consent process
  • Within 90 days of release or discharge and intending to return to Klang Valley region
  • For VTC arm, came to the C&C to start MMT
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Voluntary Treatment CenterMethadoneVoluntary drug treatment facilities, called 'Cure and Care' centers in Malaysia, that provide methadone maintenance therapy in addition to psychosocial interventions, recreational programming, and vocational training, among other activities.
Primary Outcome Measures
NameTimeMethod
Occurrence of opioid use (urine-toxicology)Year following release from CDDC or discharge from VTC
Secondary Outcome Measures
NameTimeMethod
Occurrence of any drug use (urine-toxicology)Year following release from CDDC or discharge from VTC

Includes opioid, amphetamine and benzodiazepine use

Occurrence of amphetamine use (urine-toxicology)Year following release from CDDC or discharge from VTC
Occurrence of benzodiazepine use (urine-toxicology)Year following release from CDDC or discharge from VTC
Occurrence of methadone use (urine-toxicology)Year following release from CDDC or discharge from VTC

This is a proxy for linkage to methadone therapy

Occurrence of buprenorphine use (urine-toxicology)Year following release from CDDC or discharge from VTC

This is a proxy for linkage to buprenorphine therapy

Occurrence of no-methadone use (urine-toxicology)Year following release from CDDC or discharge from VTC

This is a proxy for retention in methadone therapy

© Copyright 2025. All Rights Reserved by MedPath